VIKING THERAPEUTICS INC (VKTX)

US92686J1060 - Common Stock

74.31  +5.45 (+7.91%)

After market: 74.4 +0.09 (+0.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
114.37M100.83M70.36M55.68M42.66M
Research and Development
76.91M63.81M54.23M44.98M31.93M
Selling, General, and Administrative Expenses
37.46M37.02M16.12M10.70M10.73M
Operating Income
-114.37M-100.83M-70.36M-55.68M-42.66M
Interest Income/Expense
20.65M14.93M1.49M690.00K3.17M
Other Income/Expense
N/AN/AN/AN/AN/A
Income Before Taxes
-93.72M-85.89M-68.87M-54.99M-39.50M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-93.72M-85.89M-68.87M-54.99M-39.50M
 
Per Share Data
EPS Diluted Total Ops
-0.93-0.91-0.90-0.71-0.54
Non GAAP EPS
-0.93-0.92-0.91-0.72-0.54
 
Statistics

All data in USD

Charts